1-8 of 8
Authors: Mark G Lebwohl
Journal Article
640 - Investigator- and patient-rated local tolerability in phase 3 trials of topical roflumilast in patients with psoriasis, seborrheic dermatitis, and atopic dermatitis Get access
British Journal of Dermatology, Volume 191, Issue Supplement_2, August 2024, ljae266.021, https://doi.org/10.1093/bjd/ljae266.021
Published: 08 August 2024
Journal Article
504 - Investigator- and patient-rated local tolerability in phase 3 trials of topical roflumilast in patients with psoriasis, seborrheic dermatitis, and atopic dermatitis Get access
British Journal of Dermatology, Volume 190, Issue Supplement_2, February 2024, Pages ii9–ii10, https://doi.org/10.1093/bjd/ljad498.012
Published: 07 February 2024
Journal Article
Safety and efficacy of dual tyrosine kinase 2 inhibitor and monoclonal antibody therapy for psoriasis and psoriatic arthritis Get access
British Journal of Dermatology, Volume 190, Issue 3, March 2024, Pages 451–453, https://doi.org/10.1093/bjd/ljad473
Published: 27 November 2023
Journal Article
The Generalized Pustular Psoriasis Physician Global Assessment (GPPGA) score: online assessment and validation study of a specific measure of GPP disease activity Open Access
British Journal of Dermatology, Volume 189, Issue 1, July 2023, Pages 138–140, https://doi.org/10.1093/bjd/ljad071
Published: 19 April 2023
Journal Article
Safety of guselkumab treatment for up to 5 years in patients with moderate-to-severe psoriasis: pooled analyses across seven clinical trials with more than 8600 patient-years of exposure Open Access
British Journal of Dermatology, Volume 189, Issue 1, July 2023, Pages 42–52, https://doi.org/10.1093/bjd/ljad115
Published: 06 April 2023
Journal Article
Safety of guselkumab in patients with psoriasis with a history of malignancy: 5-year results from the VOYAGE 1 and VOYAGE 2 trials Open Access
British Journal of Dermatology, Volume 189, Issue 1, July 2023, Pages 132–134, https://doi.org/10.1093/bjd/ljad081
Published: 22 March 2023
Journal Article
Efficacy and safety of roflumilast cream for chronic plaque psoriasis with facial/neck and intertriginous area involvement: a post hoc analysis from a randomized controlled trial Open Access
British Journal of Dermatology, Volume 188, Issue 6, June 2023, Pages 810–812, https://doi.org/10.1093/bjd/ljad060
Published: 09 March 2023
Journal Article
Evaluating the role of histopathology in diagnosing pyoderma gangrenosum using Delphi and PARACELSUS criteria: a multicentre, retrospective cohort study Get access
British Journal of Dermatology, Volume 186, Issue 6, 1 June 2022, Pages 1035–1037, https://doi.org/10.1111/bjd.20967
Published: 01 June 2022
